Nanomedicines interact with lipoproteins in the blood, which might result in alterations in both nanomedicine and lipoprotein structure and function. Such interactions could also be exploited for site-specific delivery through a ‘lipoprotein Trojan Horse’ mechanism and to restore dysfunctional lipoproteins.
- S. Moein Moghimi
- Dmitri Simberg